Our study expands the understanding of circRNA function in CRC pathogenesis, and the novel circEZH2/miR-133b/IGF2BP2/CREB1 axis may be a promising diagnostic marker and therapeutic target for CRC. The gene discussed is CREB1; the disease is colorectal carcinoma.